Quote:
Originally Posted by 2020
^ Quote:
Hello, thanks for the comments! David Hall mentioned in the interview that "Phase I milestone in March is critical and we're confident that we're going to have hair growth. We're not going to go forward unless we have growth. If we achieve 20% percent growth, that would be a home run in terms of the comparative technologies out there.” RepliCel plans to release the results from the Phase I clinical trial in March, 2012.
|
Well that is good news because Replicel is continuing to raise funds in line with its original plan. Replicel just announced additional funding yesterday. According to the NBT research report (AKA mouthpiece for Replicel), on page 21, it states that "Replicel needs to complete a $5 to $10 million round of funding over the next 90-120 days to completely fund the company through Phase II trials."
Total Raised Since February 2012:
Dollars
2/29/2012 $99,456
3/29/2012 $1,314,063
4/18/2012 $754,001
4/20/2012
$645,050
Total ...... $2,812,570
Total Needed for Round II: $5-$10 Million
Round IIb Test only: $3-$4 Million
% of Round II Funding Completed:
IIB Test only 80.36% (Using average of $3.5 Million range)
Low Figure 56.25%
High Figure 28.13%
So, by deduction:
1) Hall has stated that they are not going forward unless they have hair growth
2) Replicel has raised between 28% and 56% of the range indicated they would need to fund round II testing including operating costs
3) Therefore, Replicel must have shown good results in the initial phase
Assumptions:
1) Replicel already knows the results
2) The money being raised is not being used for a revised Phase I trial
Linear Mode
